A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
During the next few months or years, vaccination against SARS-CoV-2 infection will significantly reduce the morbidity and mortality of COVID-19. However, additional measures are needed to protect those who are still not immunized. This is even more important in view of new viral mutations that result in increased transmission rates. We propose that the use of long-standing medicinal solutions based on hypochloric acid (HOCl) and intended for application on wounds may be effective as a gargling solution or nasal irrigation in blocking transmission of the virus. Here, we propose the use of HOCl-containing solutions for blocking the transmission of SARS-CoV-2 in combination with other prevention measures. This may constitute another important cornerstone in the fight against the COVID-19 pandemic.
Details
Original language | English |
---|---|
Pages (from-to) | 348-350 |
Number of pages | 3 |
Journal | Drug research : discovery, development, evaluation, translational medicine |
Volume | 71 |
Issue number | 6 |
Publication status | Published - 1 Jul 2021 |
Peer-reviewed | Yes |
External IDs
PubMed | 33890267 |
---|---|
ORCID | /0000-0003-0845-6793/work/139025236 |